Singaporean sovereign wealth fund GIC is leading a consortium buying into Vinmec, a not-for-profit hospital operator in Vietnam. This is the state investor's first investment into healthcare.
UnitedHealth Group, the largest health insurance firm in the United States, has appointed a new CEO. Andrew Witty will take the helm from outgoing CEO David Wichmann, following his three-year tenure.
Vast sums are being invested in so-called “digital health” but there remains surprisingly little medical proof that digital therapeutics, telemonitoring and coaching programmes actually work. And often so-called digital platforms merely knit together analogue processes. For instance, linking millions of diabetes patients to human counsellors and logging their blood sugar and insulin doses online may merely add huge cost without improving outcomes.
Piedmont, a region in northwest Italy, has tendered for €213m worth of home oxygen services split over two years, which could boost the market up to 20%.
Preliminary bids for Dutch, Nordic and German ambulatory and ophthalmology clinic group Bergman Clinics were due last week, HBI is told, with big-hitting PE firms expected to make offers.
HBI understands that, despite a pushed-back deadline for final bids having passed last month, there is still no buyer for UK-based dental specialist IDH. What is happening with the process as it approaches its fifth month? HBI speaks to an adviser source to find out more.
Dr. Markus Hamm is set to take over as CEO of Ober Scharrer Germany (OSG) next month, as the ophthalmology specialist reorganises the management of its German business.
Will the creditors of NMC Healthcare, the GCC's largest for-profit healthcare operator which has been in administration since April 2020, choose a sale of its core UAE business in the next 3-6 months or a longer-term, creditor-led restructuring? We talk exclusively to NMC CEO Michael Davis and UAE sources. A 'fire sale' of parts of its core UAE business now seems entirely off the table.
Diagnosing and giving therapy can be two very siloed services. Increasingly, innovators are building platforms to understand how the two could come closer together. We speak to one of the world's best-funded AI start-ups, Lunit, about its attempt to integrate diagnostics and therapeutics.
The private healthcare sector should have a large role in distributing the COVID-19 vaccine in sub-Saharan Africa alongside traditional NGO vaccine distributors. Why? Because it already has a much closer relationship to those who are most at risk, chronically ill men, HBI hears.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
